HomeRNA • NASDAQ
add
Atrium Therapeutics Inc
Previous close
$72.82
Year range
$72.75 - $73.04
Market cap
236.35M USD
Avg Volume
3.27M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 859.00K | -71.11% |
Operating expense | 15.67M | 819.24% |
Net income | -29.14M | -153.09% |
Net profit margin | -27.57K | -7,019.95% |
Earnings per share | -1.59 | -98.75% |
EBITDA | -252.98M | -3,984.97% |
Effective tax rate | -0.12% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.70B | 13.01% |
Total assets | 8.35M | 16.24% |
Total liabilities | 71.07M | 4.06% |
Total equity | -62.71M | — |
Shares outstanding | 15.51M | — |
Price to book | -18.02 | — |
Return on assets | -31.09% | — |
Return on capital | -34.63% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -29.14M | -153.09% |
Cash from operations | -19.25M | -132.99% |
Cash from investing | 207.22M | 95,154.13% |
Cash from financing | 20.13M | 137.37% |
Net change in cash | 32.36M | 121.53% |
Free cash flow | -105.47M | -60.97% |
About
CEO
Founded
2012
Website
Employees
47
